Works matching IS 13406868 AND DT 2024 AND VI 31 AND IP 6
Results: 22
21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1156, doi. 10.1007/s12282-024-01636-9
- By:
- Publication type:
- Article
Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1144, doi. 10.1007/s12282-024-01634-x
- By:
- Publication type:
- Article
Desire for pregnancy and fertility preservation in young patients with breast cancer.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1137, doi. 10.1007/s12282-024-01633-y
- By:
- Publication type:
- Article
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1114, doi. 10.1007/s12282-024-01627-w
- By:
- Publication type:
- Article
Acknowledgments to reviewers 2024.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1185, doi. 10.1007/s12282-024-01631-0
- Publication type:
- Article
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1130, doi. 10.1007/s12282-024-01630-1
- By:
- Publication type:
- Article
Reply to the Letter to the editor "Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 999, doi. 10.1007/s12282-024-01628-9
- By:
- Publication type:
- Article
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM).
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC).
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1176, doi. 10.1007/s12282-024-01626-x
- By:
- Publication type:
- Article
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1101, doi. 10.1007/s12282-024-01625-y
- By:
- Publication type:
- Article
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1092, doi. 10.1007/s12282-024-01624-z
- By:
- Publication type:
- Article
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1080, doi. 10.1007/s12282-024-01623-0
- By:
- Publication type:
- Article
Uptake of ultra-hypofractionated radiation therapy following breast-conserving surgery among patients with early-stage breast cancer: a multi-institutional questionnaire survey.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1071, doi. 10.1007/s12282-024-01621-2
- By:
- Publication type:
- Article
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?
- Published in:
- 2024
- By:
- Publication type:
- Letter
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1046, doi. 10.1007/s12282-024-01619-w
- By:
- Publication type:
- Article
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1059, doi. 10.1007/s12282-024-01618-x
- By:
- Publication type:
- Article
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1037, doi. 10.1007/s12282-024-01617-y
- By:
- Publication type:
- Article
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1018, doi. 10.1007/s12282-024-01616-z
- By:
- Publication type:
- Article
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1028, doi. 10.1007/s12282-024-01615-0
- By:
- Publication type:
- Article
Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM).
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1167, doi. 10.1007/s12282-024-01614-1
- By:
- Publication type:
- Article
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1010, doi. 10.1007/s12282-024-01613-2
- By:
- Publication type:
- Article